Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Ovarian Cancer · Platinum-sensitive Ovarian Cancer · PSOC

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mt. Sinai Comprehensive Cancer Center, Miami, Florida, United States

  • Sarasota Memorial Health Care System, Sarasota, Florida, United States

  • Miami Valley Hospital South, Centerville, Ohio, United States

  • Zangmeister Cancer Center, Columbus, Ohio, United States

  • National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan

  • Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan

  • Hyogo Cancer Center, Akashi, Hyōgo, Japan

  • Mie University Graduate School Of Medicine, Tsu, Mie-ken, Japan

  • Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan

  • Saitama Medical University International Medical Center, Hidaka, Saitama, Japan

  • The Jikei University Kashiwa Hospital, Kashiwa, Japan

  • Niigata University Medical & Dental Hospital, Niigata, Japan

  • Okayama University Hospital, Okayama, Japan

  • Kitasato University Hospital, Sagamihara, Japan

  • The Cancer Institute Hospital of JFCR, Tokyo, Japan

  • Kanagawa Prefectural Cancer Center, Yokohama, Japan

מובילי המחקר
  • Study Official

    Study Director

    Genmab